A carregar...

Efficacy and safety of chimeric antigen receptor-T cells in the treatment of B cell lymphoma: a systematic review and meta-analysis

BACKGROUND: Conventional treatment has limited efficacy in relapsed/refractory B-cell lymphoma. Since chimeric antigen receptor T-cell (CAR-T) technology has shown high safety and results in high remission rates, we investigated its efficacy and safety in B-cell lymphoma treatment and analyzed poten...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chin Med J (Engl)
Main Authors: Zheng, Xiao-Hong, Zhang, Xi-You, Dong, Qian-Qian, Chen, Feng, Yang, Shou-Bo, Li, Wen-Bin
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7028209/
https://ncbi.nlm.nih.gov/pubmed/31923107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000000568
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!